Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC
โฆ LIBER โฆ
Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma
โ Scribed by Noriyoshi Sawabata; Shinichiro Miyoshi; Akihide Matsumura; Mitsunori Ohta; Hajime Maeda; Hirofumi Sueki; Masanobu Hayakawa; Meinoshin Okumura; Yoshiki Sawa
- Publisher
- Springer Japan
- Year
- 2007
- Tongue
- Japanese
- Weight
- 201 KB
- Volume
- 55
- Category
- Article
- ISSN
- 1863-6705
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Resection of stage III non-small cell lu
โ
Valerie W. Rusch
๐
Article
๐
1995
๐
Springer
๐
English
โ 779 KB
Follow-up of local (stage I and stage II
โ
Martin J. Edelman; Julie Schuetz
๐
Article
๐
2002
๐
Springer
๐
English
โ 292 KB
Do Tumor Cavitation and Sex in Resected
Do Tumor Cavitation and Sex in Resected Stage I Non-Small-Cell Lung Cancer Correlate with Prognosis?
โ
Meng Wang; Jing Zhao; Yi Pan; Yan-Jun Su; Jian You; Xiao-Liang Zhao; Chang-Li Wa
๐
Article
๐
2008
๐
Springer
๐
English
โ 234 KB
Radiation therapy following resection of
โ
Jerry D. Slater; Nancy A. Ellerbroek; H. Thomas Barkley Jr.; Clifton Mountain; M
๐
Article
๐
1991
๐
Elsevier Science
๐
English
โ 783 KB
Intrapleural and intravenousCorynebacter
๐
Article
๐
1986
๐
Springer-Verlag
๐
English
โ 388 KB
A prospective randomized trial compared the administration of intrapleural plus intravenous Corynebacterium parvum (C. parvum) versus placebo in patients with resected Stage I and Stage II non-small cell bronchogenic carcinoma. Treatment consisted of 7 mg C. parvum injected into the pleural space an
Prognosis after resection of non-small c
โ
Haran Peleg; Joseph G. Antkowiak; Warren W. Lane; Anne-Marie Regal; Hiroshi Taki
๐
Article
๐
1987
๐
John Wiley and Sons
๐
English
โ 303 KB